Dermal Fillers Market (Product: Biodegradable and Non-biodegradable; and Material: Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-lactic Acid, PMMA, Fat, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2

Dermal Fillers Market (Product: Biodegradable and Non-biodegradable; and Material: Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-lactic Acid, PMMA, Fat, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Dermal Fillers Market – Scope of Report
TMR’s report on the global dermal fillers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global dermal fillers market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dermal fillers market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the dermal fillers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global dermal fillers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global dermal fillers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dermal fillers market.

The report delves into the competitive landscape of the global dermal fillers market. Key players operating in the global dermal fillers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global dermal fillers market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market dermal fillers.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dermal Fillers Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Dermal Fillers Market Analysis and Forecast, 2021–2031
5. Key Insights
5.1. Key Industry Developments
5.2. Dermal Fillers – Products Comparison
5.3. Dermal Filler Procedures
5.4. Regulatory Approval Process
5.5. Evolution of Dermal Fillers
5.6. Technological Advances
6. Global Dermal Fillers Market Analysis, by Product
6.1. Introduction
6.2. Global Dermal Fillers Market Value Share Analysis, by Product
6.3. Global Dermal Fillers Market Value Forecast, by Product, 2017-2031
6.3.1. Biodegradable
6.3.2. Non-biodegradable
6.4. Global Dermal Fillers Market Attractiveness Analysis, by Product
7. Global Dermal Fillers Market Analysis, by Material
7.1. Introduction
7.2. Global Dermal Fillers Market Value Share Analysis, by Material
7.3. Global Dermal Fillers Market Value Forecast, by Material, 2017-2031
7.3.1. Calcium Hydroxylapatite
7.3.2. Hyaluronic Acid
7.3.3. Collagen
7.3.4. Poly-L-Lactic Acid
7.3.5. PMMA
7.3.6. Fat
7.3.7. Others
7.4. Global Dermal Fillers Market Attractiveness Analysis, by Material
8. Global Dermal Fillers Market Analysis, by Application
8.1. Introduction
8.2. Global Dermal Fillers Market Value Share Analysis, by Application
8.3. Global Dermal Fillers Market Value Forecast, by Application, 2017-2031
8.3.1. Facial Line Correction Treatment
8.3.2. Lip Enhancement
8.3.3. Scar Treatment
8.3.4. Others
8.4. Global Dermal Fillers Market Attractiveness Analysis, by Application
9. Global Dermal Fillers Market Analysis, by End-user
9.1. Introduction
9.2. Global Dermal Fillers Market Value Share Analysis, by End-user
9.3. Global Dermal Fillers Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Dermatology Clinics
9.3.4. Others
9.4. Global Dermal Fillers Market Attractiveness Analysis, by End-user
10. Global Dermal Fillers Market Analysis, by Region
10.1. Introduction
10.2. Global Dermal Fillers Market Value Share Analysis, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Dermal Fillers Market Attractiveness Analysis, by Region
11. North America Dermal Fillers Market Analysis
11.1. Key Findings
11.2. North America Dermal Fillers Market Value Forecast, by Country, 2017-2031
11.2.1. U.S.
11.2.2. Canada
11.3. North America Dermal Fillers Market Value Forecast, by Product, 2017-2031
11.3.1. Biodegradable
11.3.2. Non-biodegradable
11.4. North America Dermal Fillers Market Value Forecast, by Material, 2017-2031
11.4.1. Calcium Hydroxylapatite
11.4.2. Hyaluronic Acid
11.4.3. Collagen
11.4.4. Poly-L-Lactic Acid
11.4.5. PMMA
11.4.6. Fat
11.4.7. Others
11.5. North America Dermal Fillers Market Value Forecast, by Application, 2017-2031
11.5.1. Facial Line Correction Treatment
11.5.2. Lip Enhancement
11.5.3. Scar Treatment
11.5.4. Others
11.6. North America Dermal Fillers Market Value Forecast, by End-user, 2017-2031
11.6.1. Hospitals
11.6.2. Ambulatory Surgical Centers
11.6.3. Dermatology Clinics
11.6.4. Others
11.7. North America Market Attractiveness Analysis
11.7.1. By Country
11.7.2. By Product
11.7.3. By Material
11.7.4. By Application
11.7.5. By End-user
12. Europe Dermal Fillers Market Analysis
12.1. Key Findings
12.2. Europe Dermal Fillers Market Value Forecast, by Country/Sub-region, 2017-2031
12.2.1. U.K.
12.2.2. Germany
12.2.3. France
12.2.4. Italy
12.2.5. Spain
12.2.6. Rest of Europe
12.3. Europe Dermal Fillers Market Value Forecast, by Product, 2017-2031
12.3.1. Biodegradable
12.3.2. Non-biodegradable
12.4. Europe Dermal Fillers Market Value Forecast, by Material, 2017-2031
12.4.1. Calcium Hydroxylapatite
12.4.2. Hyaluronic Acid
12.4.3. Collagen
12.4.4. Poly-L-Lactic Acid
12.4.5. PMMA
12.4.6. Fat
12.4.7. Others
12.5. Europe Dermal Fillers Market Value Forecast, by Application, 2017-2031
12.5.1. Facial Line Correction Treatment
12.5.2. Lip Enhancement
12.5.3. Scar Treatment
12.5.4. Others
12.6. Europe Dermal Fillers Market Value Forecast, by End-user, 2017-2031
12.6.1. Hospitals
12.6.2. Ambulatory Surgical Centers
12.6.3. Dermatology Clinics
12.6.4. Others
12.7. Europe Market Attractiveness Analysis
12.7.1. By Country/Sub-region
12.7.2. By Product
12.7.3. By Material
12.7.4. By Application
12.7.5. By End-user
13. Asia Pacific Dermal Fillers Market Analysis
13.1. Key Findings
13.2. Asia Pacific Dermal Fillers Market Value Forecast, by Country/Sub-region, 2017-2031
13.2.1. China
13.2.2. Japan
13.2.3. India
13.2.4. Australia
13.2.5. Rest of Asia Pacific
13.3. Asia Pacific Dermal Fillers Market Value Forecast, by Product, 2017-2031
13.3.1. Biodegradable
13.3.2. Non-biodegradable
13.4. Asia Pacific Dermal Fillers Market Value Forecast, by Material, 2017-2031
13.4.1. Calcium Hydroxylapatite
13.4.2. Hyaluronic Acid
13.4.3. Collagen
13.4.4. Poly-L-Lactic Acid
13.4.5. PMMA
13.4.6. Fat
13.4.7. Others
13.5. Asia Pacific Dermal Fillers Market Value Forecast, by Application, 2017-2031
13.5.1. Facial Line Correction Treatment
13.5.2. Lip Enhancement
13.5.3. Scar Treatment
13.5.4. Others
13.6. Asia Pacific Dermal Fillers Market Value Forecast, by End-user, 2021–2031
13.6.1. Hospitals
13.6.2. Ambulatory Surgical Centers
13.6.3. Dermatology Clinics
13.6.4. Others
13.7. Asia Pacific Market Attractiveness Analysis
13.7.1. By Country/Sub-region
13.7.2. By Product
13.7.3. By Material
13.7.4. By Application
13.7.5. By End-user
14. Latin America Dermal Fillers Market Analysis
14.1. Key Findings
14.2. Latin America Dermal Fillers Market Value Forecast, by Country/Sub-region, 2017-2031
14.2.1. Brazil
14.2.2. Mexico
14.2.3. Rest of Latin America
14.3. Latin America Dermal Fillers Market Value Forecast, by Product, 2017-2031
14.3.1. Biodegradable
14.3.2. Non-biodegradable
14.4. Latin America Dermal Fillers Market Value Forecast, by Material, 2017-2031
14.4.1. Calcium Hydroxylapatite
14.4.2. Hyaluronic Acid
14.4.3. Collagen
14.4.4. Poly-L-Lactic Acid
14.4.5. PMMA
14.4.6. Fat
14.4.7. Others
14.5. Latin America Dermal Fillers Market Value Forecast, by Application, 2017-2031
14.5.1. Facial Line Correction Treatment
14.5.2. Lip Enhancement
14.5.3. Scar Treatment
14.5.4. Others
14.6. Latin America Dermal Fillers Market Value Forecast, by End-user, 2017-2031
14.6.1. Hospitals
14.6.2. Ambulatory Surgical Centers
14.6.3. Dermatology Clinics
14.6.4. Others
14.7. Latin America Market Attractiveness Analysis
14.7.1. By Country/Sub-region
14.7.2. By Product
14.7.3. By Material
14.7.4. By Application
14.7.5. By End-user
15. Middle East & Africa Dermal Fillers Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Dermal Fillers Market Value Forecast, by Country/Sub-region, 2017-2031
15.2.1. GCC Countries
15.2.2. South Africa
15.2.3. Rest of Middle East & Africa
15.3. Middle East & Africa Dermal Fillers Market Value Forecast, by Product, 2017-2031
15.3.1. Biodegradable
15.3.2. Non-biodegradable
15.4. Middle East & Africa Dermal Fillers Market Value Forecast, by Material, 2017-2031
15.4.1. Calcium Hydroxylapatite
15.4.2. Hyaluronic Acid
15.4.3. Collagen
15.4.4. Poly-L-Lactic Acid
15.4.5. PMMA
15.4.6. Fat
15.4.7. Others
15.5. Middle East & Africa Dermal Fillers Market Value Forecast, by Application, 2017-2031
15.5.1. Facial Line Correction Treatment
15.5.2. Lip Enhancement
15.5.3. Scar Treatment
15.5.4. Others
15.6. Middle East & Africa Dermal Fillers Market Value Forecast, by End-user, 2017-2031
15.6.1. Hospitals
15.6.2. Ambulatory Surgical Centers
15.6.3. Dermatology Clinics
15.6.4. Others
15.7. Middle East & Africa Market Attractiveness Analysis
15.7.1. By Country/Sub-region
15.7.2. By Product
15.7.3. By Material
15.7.4. By Application
15.7.5. By End-user
16. Competitive Landscape
16.1. Competition Matrix
16.2. Company Profiles
16.2.1. AbbVie Inc.
16.2.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. SWOT Analysis
16.2.1.5. Strategic Overview
16.2.2. Sinclair
16.2.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. SWOT Analysis
16.2.2.4. Strategic Overview
16.2.3. Merz Pharma
16.2.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. SWOT Analysis
16.2.3.5. Strategic Overview
16.2.4. GALDERMA
16.2.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. SWOT Analysis
16.2.4.5. Strategic Overview
16.2.5. BioPlus Co., Ltd.
16.2.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. SWOT Analysis
16.2.5.4. Strategic Overview
16.2.6. Bioxis pharmaceuticals
16.2.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. SWOT Analysis
16.2.7. SCULPT Luxury Dermal Fillers LTD
16.2.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. SWOT Analysis
16.2.8. DR. Korman
16.2.8.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. SWOT Analysis
16.2.9. Prollenium Medical Technologies
16.2.9.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. SWOT Analysis
16.2.10. Advanced Aesthetic Technologies, Inc.
16.2.10.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. SWOT Analysis
16.2.11. TEOXANE Laboratories
16.2.11.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.11.2. Financial Overview
16.2.11.3. Product Portfolio
16.2.11.4. SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings